Обучение по природни науки и върхови технологии

Учебен експеримент в природните науки

SIMULTANEOUS ESTIMATION OF IBUPROFEN AND RANITIDINE HYDROCHLORIDE USING UV SPECTROPHOTOMETRIC METHOD

Резюме. A new method has been developed for the simultaneous estimation of ibuprofen and ranitidine HCl using UV spectroscopy. The calibration graphs were linear in the ranges of \(2-12 \mu \mathrm{~g} / \mathrm{ml}\) for ibuprofen (\(\mathrm{r}^{2}=0.9994\) ) and \(5-30 \mu \mathrm{~g} / \mathrm{ml}\) for ranitidine \(\mathrm{HCl}\left(\mathrm{r}^{2}=0.9992\right)\). The values of limit of detection (LOD) and limit of quantification (LOQ) were determined 0.0196 and 0.0656 for ibuprofen and 0.0114 and 0.0379 for ranitidine HCl, respectively. RSD values for various determinations were found less than 1, which indicated good accuracy and precision of the method. The newly developed method was successfully applied for simultaneous estimation of two combination drugs, ibuprofen and ranitidine HCl in pharmaceutical tablets containing ibuprofen and ranitidine HCl.

Ключови думи: ibuprofen, ranitidine hydrochloride, simultaneous estimation, UV spectroscopy

Introduction

Ibuprofen, 2- (4- isobutyl– phenyl) propionic acid is a non-steroidal anti-inflammatory drug (NSAID) with a half-life of \(1.8-2 \mathrm{~h}\), and commonly used in the treatment of arthritis, post-operative and dental pain (Eiche et al., 2009; Issa et al., 2011; Hasnain & Nayak, 2012). Ibuprofen is used in the management of mild to moderate pain and inflammation in condition such as headache including migraine, postoperative pain, musculoskeletal and joint disorders such as alkylosing spondylitis, osteoarthritis and rheumatoid arthritis (Eiche et al., 2009). Ranitidine, N, N- dimethyl- 5- [2- (1- methyl amino- 2- nitro vinyl amino) ethyl thio methyl] furfuryl amine, is a \(\mathrm{H}_{2}\)-antagonist with a half-life of \(2.5-3 \mathrm{~h}\), which inhibits the gastric acid secretion and pepsin output (Grant, 1989). It is widely prescribed in active duodenal ulcers, gastric ulcers, Zollinger-Ellison syndrome, gastroesophageal reflux disease, and erosive esophagitis. \({ }^{1)}\)

The literature survey reveals that some UV-spectrophotometric methods for estimation of ibuprofen (Benjamin et al., 2009; Gondalia, et al., 2010; Patel & Rajput, 2012) and for ranitidine (Raut & Sabnis, 1987; Haque et al., 2008; Salve et al., 2010) alone or combination with various drugs have been reported. However, any analytical method for simultaneous estimation of ibuprofen with ranitidine hydrochloride is still not reported. In the present investigation, we made a plan to develop a simple method for simultaneous estimation of ibuprofen with ranitidine hydrochloride in pharmaceutical preparations using UV spectroscopy.

e xperimental

Materials

Ibuprofen and ranitidine HCl were obtained from B. S. Traders Pvt. Ltd., India. All other chemicals and reagents used were of analytical grade.

Instrument

An UVVIS Spectrophotometer (Thermo Spectronic UV-1, USA) with matched quartz cell corresponding to 1 cm path length and spectral bandwidth 1 nm was employed for simultaneous determination ibuprofen and ranitidine HCl.

Preparation of standard stock solution

Two standard stock solutions of \(100 \mu \mathrm{~g} / \mathrm{ml}\) were prepared for ibuprofen and ranitidine HCl after dissolving the 10 mg drugs in a \(50 \% \mathrm{v} / \mathrm{v}\) methanol solution and working standard solution of both drugs prepared on the day of analysis by suitable dilution of the stock solution with methanol.

Determination of maximum wavelength (λmax) imum wavelength (\(\lambda_{\max }\)

In this study, the stock solution of both drugs was carefully diluted with \(50 \% \mathrm{v} / \mathrm{v}\) methanol solution to \(10 \mu \mathrm{~g} / \mathrm{ml}\) of ibuprofen and ranitidine HCl. Then all samples were scanned separately in the range of \(200-350 \mathrm{~nm}\) to detect \(\lambda_{\text {max }}\) for ibuprofen and ranitidine HCl, separately.

Simultaneous equation method

The stock solution of both drugs were further diluted with \(50 \% \mathrm{v} / \mathrm{v}\) methanol solution to get a series of standard drug solution, i.e. \(2-12 \mu \mathrm{~g} / \mathrm{ml}\) for ibuprofen and \(5-30 \mu \mathrm{~g} / \mathrm{ml}\) for ranitidine HCl. Absorbances were measured at the selected wavelengths and absorptivities. Drugs were determined as mean of six independent determinations. Concentration in the sample was determined by using following equation (Dey et al., 2012):

\[ \begin{aligned} & C_{x}=\left(A_{2} \cdot a_{1}-A_{1} \cdot a_{2}\right) /\left(a_{2} \cdot a y_{2}-a x_{1} \cdot a y_{2}\right) \\ & C_{y}=\left(A_{1} \cdot a x_{2}-A_{2} \cdot a x_{1}\right) /\left(a_{2} \cdot a y_{1}-a x_{1} \cdot a y_{2}\right) \end{aligned} \]

where \(\mathrm{A}_{1}\) and \(\mathrm{A}_{2}=\) absorbance of mixture at \(221 \mathrm{~nm}\left(\lambda_{1}\right)\) and \(314 \mathrm{~nm}\left(\lambda_{2}\right)\), respectively; \(\mathrm{ax}_{1}\) and \(\mathrm{ax}_{2}=\) absorptivity of ibuprofen at \(\lambda_{1}\) and \(\lambda_{2}\), respectively; ay1 and ay \({ }_{2}=\) absorptivity of ranitidine HCl at \(\lambda_{1}\) and \(\lambda_{2}\), respectively; \(\mathrm{C}_{\mathrm{x}}=\) concentration of ibuprofen; \(\mathrm{C}_{\mathrm{y}}=\) concentration of ranitidine HCl.

Validation of method

Any newly developed method needs proper validation for its application in various respects. Here the method was validated in compliance with ICH guidelines (Dey et al., 2012). The following studies were performed for validation purpose.

Linearity: A linear relationship between absorbances and concentration was found for ibuprofen at concentration range of \(2-12 \mu \mathrm{~g} / \mathrm{ml}\) and ranitidine HCl at concentration range of \(5-30 \mu \mathrm{~g} / \mathrm{ml}\), where 5 replicates of measurement were performed in each case.

Precision: The term precision is well required for any method validation and here it was determined by repeatability measurement and intermediate precision study, where measurement of absorbance was done by performing six replicates of measurement of same using a sample solution.

Recovery studies: In recovery studies, three different known concentration of standard drugs solution were added to the drug product as standard addition method. Therefore \(8,10,12 \mu \mathrm{~g} / \mathrm{ml}\) of ibuprofen and \(16,20,24 \mu \mathrm{~g} / \mathrm{ml}\) of ranitidine HCl were added to the dosage form that contained \(10 \mu \mathrm{~g} / \mathrm{ml}\) of Ibuprofen and \(20 \mu \mathrm{~g} / \mathrm{ml} \mathrm{HCl}\) after proper sample dilution.

Limit of detection (LOD) and limit of quantification (LOQ): The LOD and LOQ study are extensively needed method validation in simultaneous estimation of various drugs in dosage form and these were calculated by taking the standard deviation of the y-intercept and slope of the calibration curve of selected drugs. The formula for determination of LOD and LOQ are given below:

\[ \begin{aligned} & \text { Limit of detection (LOD) }=3 \alpha / \mathrm{S} \\ & \text { Limit of quantification }(\mathrm{LOQ})=10 \alpha / \mathrm{S} \end{aligned} \]

where \(\alpha\) is referred as standard deviation of y-intercept and S is referred as slope of the standard curve.

Robustness: Robustness is essential to detect the effect on absorbance in terms deliberate variation in the method parameter like wavelength (\(\lambda_{1}\) ), pH and calculation of robustness is based on relative standard deviation of each parameter.

Determination of drug content in tablet containing ibuprofen and ranitidine HCl: The bi-layers tablets prepared by compressing the 400 mg of ibuprofen and 150 mg of ranitidine HCl along with suitable excipients using 12 mm flat punches. 20 tablets were taken and crushed in a pestle and mortar. The accurately weighed powder sample equivalent to 400 mg ibuprofen and 150 mg of ranitidine HCl was subjected to a 100 ml volumetric flux and diluted followed by sonication with \(50 \% \mathrm{v} / \mathrm{v}\) methanol solution to dissolve the sample. The solution was then filtered through Whatmann \({ }^{\circledR}\) filter paper (No. 40) and 0.1 ml filtrate was further diluted with same diluting solution and analyzed by multicomponent mode of analysis in a UV-VIS spectrophotometer (Thermo Spectronic UV-1, USA), where \(50 \% \mathrm{v} / \mathrm{v}\) aqueous methanol solution was used as blank.

Results and discussion

An UV-spectrophotometric method was developed for simultaneous estimation of ibuprofen and ranitidine HCl in tablet dosage form. The \(\lambda_{\max } \mathrm{S}\) were found to be 221 nm for the ibuprofen and 314 nm ranitidine HCl in \(50 \% \mathrm{v} / \mathrm{v}\) aqueous methanol solution as solvent. An overlaid spectrum was shown in Fig. 1.

Linearity

Linearity generally depends on the correlation coefficient (\(\mathrm{r}^{2}\) ) between the absorbance with its respective concentrations. In this investigation, \(\mathrm{r}^{2}\) was found to be 0.9994 for ibuprofen and 0.9992 for ranitidine HCl. The \(\mathrm{r}^{2}\) values were obtained from calibration curve constructed in the concentration range of \(2-12 \mu \mathrm{~g} / \mathrm{ml}\) for ibuprofen and \(5-30 \mu \mathrm{~g} /\) ml for ranitidine HCl shown in Table 1.

Fig. 1. Overlaid spectra of ibuprofen and ranitidine hydrochloride

Precision

Precision determined in terms of repeatability and intermediate precision studies were expressed as relative standard deviation (RSD) of the absorbance. The results represented the repeatability, intra-day and inter-day variation in absorbance at concentration of 10 \(\mu \mathrm{g} / \mathrm{ml}\) for ibuprofen and \(20 \mu \mathrm{~g} / \mathrm{ml}\) for ranitidine HCl and these values were found within the acceptable range (less than \(1 \%\) for both drugs shown in Table 1).

Table 1. Summary of linear regression and validation data

Parameters*IbuprofenRanitidine HClWavelength (nm) 222.0 nm314.0 nmLinearity range(µg/ml) 2-125-30Linear regression equationY= 0.0381+ 0.0015Y= 0.0633 - 0.0025Slope ± SD0.0381 ± 0.000350.0633 ± 0.00033Intercept ± SD0.0015 ± 0.000250.0025 ± 0.00024Correlation coefcient (r2) 0.99940.9992Limit of detection (LOD) 0.01960.01147Limit of quantication (LOQ) 0.06560.0379Repeatability (RSD) 0.5820.352Intra-day (RSD) 0.4420.376Inter-day (RSD) 0.5310.341* Represents average of six estimations (n = 6)

Recovery studies

The recovery studies were performed taking the concentration level at 80, 100 and \(120 \%\) for test samples as per ICH guidelines. The percentage recovery all the three levels are shown in Table 2 and results were found satisfactory. The percentage recovery was laid in range between 0.443 to 0.531 for ibuprofen and 0.376 to 0.341 for ranitidine HCl.

Table 2. Recovery studies (standard addition method)

DrugRecoverylevel EB) Initial amount(µg/ml) Amount add-ed (µg/ml) % Recovery*% RSD*Ibuprofen8010012020202016202498.19 ± 0.1698.25 ± 0.1598.60 ± 0.280.1600.1520.286RanitidineHCl8010012020202016202498.76 ± 0.1198.95 ± 0.0999.49 ± 0.400.1060.0900.404* Represents average of three estimations (n = 3)

Limit of detection (LOD) and limit of quantification (LOQ)

The values of LOD and LOQ were determined 0.0196 and 0.0656 for ibuprofen and 0.0114 and 0.0379 for ranitidine HCl, respectively, that confers the sensitivity of developed method.

Table 3. Robustness study of variation in method parameters

DrugParametersConc. used(µg/ml) Mean*conc. obtained(µg/ml) SD*%RSD*IbuprofenWavelength (λ) 223 nm109.900.210.207221nm109.960.090.091219 nm109.880.210.216pH1.4109.850.200.1971.2109.940.080.0811.0109.810.190.195RanitidineHClWavelength (λ) 316 nm2019.740.210.210314 nm2019.910.110.109312 nm2019.820.210.212pH1.42019.840.190.1871.22019.940.080.0841.02019.860.200.197

Robustness

Table 3 represents that all the values for robustness in developed method were found less than \(1 \%\) (RSD values) and assure the robustness of method.

Determination of drugs content in tablets containing ibuprofen and ranitidine HCl

The prepared bi-layered tablets containing 400 mg of ibuprofen and 150 mg ranitidine HCl was assayed using the developed method. The assay results of tablets are displayed in Table 4. The RSD values less than \(1 \%\) concludes that the developed method is accurate and precise.

Table 4. Analysis of drug content in tablet containing ibuprofen and ranitidine hydrochloride

DrugLabel claim% Mean assay*SD*% RDS*Ibuprofen400 mg101.090.230.226Ranitidine HCl150 mg100.660.550.544

Conclusion

The developed method was found simple, rapid and permit direct and simultaneous determination of ibuprofen and ranitidine HCl. RSD values for various determinations were found less than 1, which indicated good accuracy and precision of the method. Moreover, the new method is used for the determination of the two combination drugs, ibuprofen and ranitidine HCl in pharmaceutical preparation, where several excipients are present.

NOTES

1. Patel, D.M., Patel, N.M., Patel, V.F. & Bhatt, D.A. (2007) . Floating granules of ranitidine hydrochloride-Gelucire 43/01: Formulation optimization using factorial design. AAPS PharmSciTech., 8, article 30.

REFERENCES

Benjamin, U.E., Kehinde, E.O., Augustine, A.A. & James, O. (2009). Comparative utilization of visual, potentiometric titrations and UV spectrophotometric methods in the determination of ibuprofen. African J. Pharm. Pharmacol., 3, 426-431.

Dey, S., Sarkar, S., Malakar, J., Ghosh, A., Gangopadhayay, A. & Majumdar B. (2012). Spectrophotometric method for simultaneous determination for atenolol and atorvastatin in tablet dosage form. Int. J. Pharm. Biomed. Res., 3, 40-43.

Eichie, F.E., Arhewoh, I.M. & Ezeobi, O.C. (2009). In-vitro evaluation of the pharmaceutical quality of some ibuprofen tablets dispensed in Nigeria. African J. Pharm. Pharmacol., 3, 491-495.

Gondalia, R., Mashru, R. & Savaliya, P. (2010). Development and validation of spectrophotometric methods for simultaneous estimation of ibuprofen and paracetamol in soft gelatin capsule by simultaneous equation method. Int. J. Chem. Techn. Res., 2, 1881-1885.

Grant, S.M. (1989). Ranitidine: an updated review of its pharmacodynamic and pharmacokinetics properties and therapeutic uses in peptic ulcer decease. Drugs, 37, 801–870.

Haque, T., Talukder, M.M.U., Laila, S., Fatema, K. & Kabir, A.K.L. (2008). Simultaneous estimation of naproxen and ranitidine HCl by using UV spectrophotometer. Stamford J. Pharm. Sci., 1, 18-24.

Hasnain, M.S. & Nayak, A.K. (2012). Solubilty and dissolution enhancement of ibuprofen by solid dispersion technique using PEG 6000-PVP K 30 combination carrier. Chemistry, 21, 118-132.

Issa, Y.M, Zayed, S.I.M. & Habib I.H.T. (2011). Simultaneous determination of ibuprofen and paracetamol using derivatives of the ratio spectra method. Arabian J. Chem., 4, 259-263.

Patel, A. & Rajput S.J. (2012). Development and validation of spectrophotometric methods for simultaneous estimation of ibuprofen and famotidine in combined pharmaceutical formulation. American J. PharmTech. Res., 2, 593-601.

Raut, K.N. & Sabnis, S.D. (1987). A new spectrophotometric method for estimation of ranitidine hydrochloride. Indian J. Pharm. Sci., 49, 65-66.

Salve, P., Gharge, D., Kirtawade, R., Dhabale, P. & Burade, K. (2010). Simple validated spectroscopic method for estimation of ranitidine from tablet formulation. Int. J. PharmTech Res., 2, 2071-2074.

Година XXI, 2012/5 Архив

стр. 692 - 699 Изтегли PDF